Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Downgrades Fate Therapeutics to Market Perform

Cowen & Co. Downgrades Fate Therapeutics to Market Perform

Cowen & Co. analyst Tyler Van Buren downgrades Fate Therapeutics (NASDAQ:FATE) from Outperform to Market Perform.

January 6, 2023

1 minute read

Cowen & Co. analyst Tyler Van Buren downgrades Fate Therapeutics (NASDAQ:FATE) from Outperform to Market Perform.

HC Wainwright & Co. Maintains Buy on Kopin, Lowers Price Target to $3

March 15, 6:09 AM

HC Wainwright & Co. analyst Kevin Dede maintains Kopin (NASDAQ:KOPN) with a Buy and lowers the price target from $6 to $3.

September 28, 8:00 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Everbridge Inc (NASDAQ: EVBG) as it does not make money.

January 25, 7:16 AM

Sweden-based Volvo Cars is recalling about 106,900 cars globally.

March 3, 4:01 PM

Over the past 3 months, 12 analysts have published their opinion on Carvana (NYSE:CVNA) stock. These analysts are…